Who Generates More Revenue? Johnson & Johnson or Bausch Health Companies Inc.

Johnson & Johnson's revenue dominance over Bausch Health.

__timestamp	Bausch Health Companies Inc.	Johnson & Johnson
Wednesday, January 1, 2014	8263500000	74331000000
Thursday, January 1, 2015	10498800000	70074000000
Friday, January 1, 2016	9674000000	71890000000
Sunday, January 1, 2017	8724000000	76450000000
Monday, January 1, 2018	8380000000	81581000000
Tuesday, January 1, 2019	8601000000	82059000000
Wednesday, January 1, 2020	8027000000	82584000000
Friday, January 1, 2021	8434000000	78740000000
Saturday, January 1, 2022	8124000000	79990000000
Sunday, January 1, 2023	8757000000	85159000000
Monday, January 1, 2024		61350000000

Unveiling the hidden dimensions of data

Revenue Showdown: Johnson & Johnson vs. Bausch Health

In the competitive landscape of the healthcare industry, revenue generation is a key indicator of a company's market strength. Over the past decade, Johnson & Johnson has consistently outperformed Bausch Health Companies Inc. in terms of annual revenue. From 2014 to 2023, Johnson & Johnson's revenue has averaged around $78 billion annually, dwarfing Bausch Health's average of approximately $8.7 billion.

A Decade of Dominance

Johnson & Johnson's revenue peaked in 2023 at $85 billion, marking a 15% increase from its 2014 figures. In contrast, Bausch Health's highest revenue was recorded in 2015, with a 27% increase from the previous year, but it has since stabilized around $8 billion annually. This data highlights Johnson & Johnson's robust growth and market leadership, while Bausch Health maintains a steady, albeit smaller, presence in the industry.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025